Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. BioNTech said Thursday it would buy ...

BioNTech sails into ASCO with two clinical readouts that underscore its pivot toward oncology beyond vaccines, even as the stock trades under mid-year pressure and investors weigh the pace of the ...

Fintel reports that on May 27, 2026, UBS upgraded their outlook for BioNTech SE - Depositary Receipt (NasdaqGS:BNTX) from ...

FRANKFURT (Reuters) -BioNTech said on Thursday that its collaboration with Pfizer has not changed, when asked to comment on a report that Pfizer is looking to sell its stake in the German biotech firm ...

Pumitamig data from the ongoing Phase 2/3 ROSETTA Lung-02 trial in first-line non-small cell lung cancer mark the third global data set to ...

Five additional pivotal trials for pumitamig initiated during 2026 in collaboration with Bristol Myers SquibbOncology pipeline strength and ...

On the other, the oncology pipeline is about to face its most public scrutiny yet at the American Society of Clinical Oncology meeting in Chicago, where new data on pumitamig and gotistobart will ...

An update from BioNTech SE ( (BNTX) ) is now available.

When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some financial analysts said the buyout amounted to an out-of-court settlement of ...

German vaccine manufacturer BioNTech, which rose to global prominence with its Covid-19 vaccine developed alongside Pfizer, plans to close several production sites, with up to 1,860 jobs affected. The ...

View BioNTech SE Sponsored ADR BNTX stock quote prices, financial information, real-time forecasts, and company news from CNN.

BioNTech’s messenger RNA technology led to a successful Covid-19 vaccine that provides it with plenty of cash for pipeline expansion. The company is deploying some of that capital in a new partnership ...